IGMS - Total Utang marang Modal IGM Biosciences

Logo perusahaan publik IGM Biosciences Inc. (IGMS)

This price chart illustrates the dynamics of the separate_debt_total_eq metric, which currently stands at 0.00. IGM Biosciences, Inc. (IGMS) develops cutting-edge immunotherapies, leveraging partnerships with global industry behemoths to combat tumors. Business revenues are based on the integration of targeted biologics into the insurance system. Stable demand for medical innovations renders this sector a defensive asset, independent of external economic shocks.

IGMS: Total Utang marang Modal IGM Bio 04.07.2022 - 24.08.2025

Rincian analitis perusahaan IGM Biosciences, Inc.

- rega lan prakiraan konsensus rega:
Bagan rega IGM Biosciences Inc.|IGMS - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar IGM Biosciences|IGMS - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham IGM Biosciences|IGMS - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku igmbio.com|IGMS - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas IGM Biosciences, Inc.|IGMS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal IGM Biosciences Inc.|IGMS - Gunggung utang perusahaan|Utang marang nilai buku IGM Biosciences|IGMS - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan IGM Biosciences|Likuiditas cepet igmbio.com
- informasi bathi lan kelipatan valuasi:
IGMS - Penghasilan resik
Analisis dhasar perusahaan:IGM Biosciences, Inc.
Barang utama IGM Biosciences

The financial stability of IGM Biosciences, Inc. (IGMS) is determined by the success of clinical trials and the support of strategic partners, which directly impacts the need for borrowed capital. This leverage metric—the ratio of total debt to equity—measures the proportion of credit funds within the balance sheet structure relative to equity, allowing for an assessment of the debt load and bankruptcy risks through an analysis of the chart's dynamics.

Analisis pesaing IGM Biosciences, Inc.

Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|Pieris Pharmaceuticals Inc - Total Utang marang Modal|Koefisien Total Utang marang Modal Savara Pharma SVRA|RIGL: Total Utang marang Modal|Rasio Utang marang Modal anaptysbio.com ANAB|Utang marang Ekuitas Astria Therapeutics, Inc.|Rasio Total Utang marang Ekuitas enGene Holdings Inc (ENGN)|Rasio Total Utang marang Ekuitas RAPT (RAPT Therapeutics, Inc.)|JBIO (aerovatetx.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ACRS (Aclaris Therapeutics)|kyvernatx.com - Utang marang Ekuitas|Tiziana Life Sciences Ltd - Total Utang marang Modal|Koefisien Total Utang marang Modal Cabaletta Bio Inc. CABA|Ventyx Bio (VTYX) - Utang marang Ekuitas|Utang marang Modal Theratechnologies, Inc (THTX)|Utang marang Ekuitas Avalo Therapeutics, Inc|eledon.com (ELDN) - Koefisien Total Utang marang Modal|Total Utang marang Modal AGEN|Rasio Total Utang marang Ekuitas Climb Bio Inc. CLYM|Total Utang marang Modal ZURA (Zura Bio Limited)|Koefisien Total Utang marang Modal aTyr Pharmaceuticals (ATYR)|Adagene Corp - Total Utang marang Modal|Utang marang Modal ImageneBio Inc|shattucklabs.com (STTK) - Utang marang Ekuitas|Rasio Utang marang Ekuitas EQ|CNTB (Connect Biopharma Holdings) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Immunic Inc (IMUX)|Total Utang marang Modal ATRA|IFRX - Utang marang Modal|Utang marang Ekuitas X4 Pharmaceuticals, Inc. XFOR|Koefisien Total Utang marang Modal Adicet Bio Inc. (ACET)|CELU: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi INMB (INmune Bio Corporation)|BRNS: Total Utang marang Modal|KZR - Koefisien Total Utang marang Modal|Utang marang Ekuitas SAB Biotherapeutics, Inc.|Rasio Utang marang Ekuitas AKTX (Akari Therapeutics PLC)|Total Utang marang Modal ENLV|Rasio Total Utang marang Ekuitas q32bio.com QTTB|GeoVax Labs, Inc. - Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal edesabiotech.com (EDSA)|iBio - Total Utang marang Modal|Koefisien Total Utang marang Modal Carisma Therapeutics CARM|XTLB: Total Utang marang Modal|Rasio Utang marang Modal Bolt Biotherapeutics, Inc. BOLT|Utang marang Ekuitas HCW Biologics, Inc.|Rasio Total Utang marang Ekuitas Aptevo (APVO)|Utang marang Ekuitas AIM ImmunoTech (AIM)|Koefisien Total Utang marang Modal aditxt.com|Utang marang Ekuitas GRI Bio Corp GRI|XRTX (XORTX Corp) - Utang Agregat marang Ekuitas|Vyome Holdings Inc - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi REVB (revbiosciences.com)|INDP: Total Utang marang Modal|Scinai Immunotherapeutics Ltd (SCNI) - Total Utang marang Modal|Utang marang Ekuitas CalciMedica Inc|AFMD: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Allakos Inc. (ALLK)|Rasio Total Utang marang Ekuitas hookipapharma.com HOOK|Total Utang marang Modal ITOS (iTeos Therapeutics, Inc.)|Total Utang marang Modal Ocean Biomedical Inc OCEA|TCBP: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi THRD (Third Harmonic Bio Inc)